Skip to main content

ODEFSEY

NDC 61958-2101 · Gilead Sciences, Inc.

Generic nameemtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide
Dosage formTABLET
RouteORAL
Active ingredient(s)EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, TENOFOVIR ALAFENAMIDE FUMARATE
Strength200; 25; 25 mg/1; mg/1; mg/1
Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Non-Nucleoside Analog [EXT], Non-Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]
Marketing categoryNDA

Packages

61958-2101-1 — 30 TABLET in 1 BOTTLE, PLASTIC (61958-2101-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

61958-0602 — EMTRICITABINE, 61958-0701 — emtricitabine and tenofovir disoproxil fumarate, 61958-0703 — emtricitabine and tenofovir disoproxil fumarate, 61958-0704 — emtricitabine and tenofovir disoproxil fumarate, 61958-0705 — emtricitabine and tenofovir disoproxil fumarate, 61958-1101 — emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate, 61958-1201 — elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate, 61958-1901 — elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide, 61958-2002 — emtricitabine and tenofovir alafenamide, 61958-2005 — emtricitabine and tenofovir alafenamide, 61958-2301 — tenofovir alafenamide, 61958-2501 — bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate, 61958-2505 — bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate, 61958-2506 — bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate, 64380-719 — EMTRICITABINE and TENOFOVIR Disoproxil Fumarate, 65862-301 — Emtricitabine, 65862-354 — Emtricitabine and Tenofovir Disoproxil Fumarate, 65862-497 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 67296-2198 — Emtricitabine and tenofovir disoproxil fumarate, 68071-2112 — emtricitabine and tenofovir disoproxil fumarate, +58 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.